908 DevicesMASS -2.19%70 Receivables Turnover is 1.26 as of Mar. 2026. GuruFocus rates MASS with a GF Score™ of 70/100 and a GF Value™ of $6.96 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 812 Medical Devices & Instruments companies, 908 Devices ranks better than 61.58% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. 908 Devices's Revenue for the
three
months ended in Mar. 2026 was $13.38 Mil. 908 Devices's average Accounts Receivable for the
three
months ended in Mar. 2026 was $10.60 Mil.
Hence, 908 Devices's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.26.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
908 Devices Receivables Turnover Related Terms
908 Devices Receivables Turnover Historical Data
* Premium members only.
The historical data trend for 908 Devices's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MASS vs ELMD, CATX, SGHT: Receivables Turnover Comparison
For the Medical Devices subindustry, 908 Devices's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where 908 Devices's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
908 Devices (MASS) has a Receivables Turnover of 1.26 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on 908 Devices and its competitors. According to the industry distribution chart, 908 Devices ranks #312 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 38.4%.
Is 908 Devices' Receivables Turnover too high?
908 Devices' current Receivables Turnover is 1.26. The Medical Devices & Instruments industry median Receivables Turnover is 5.53. 908 Devices' value of 1.26 is 77.2% below this industry median. Based on the distribution chart, 908 Devices ranks #312 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, 908 Devices has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' Receivables Turnover compare to ELMD and CATX?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #312 out of 812 companies for Receivables Turnover. This puts 908 Devices in the upper half of its industry. The industry median Receivables Turnover is 5.53. 908 Devices' value of 1.26 is 77.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.53, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 908 Devices's current Receivables Turnover of 1.26 is 77.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on 908 Devices and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current Receivables Turnover is 1.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.96, compared to a current price of $8.68 — trading 24.7% above its estimated fair value. The current Receivables Turnover is 1.26 and 77.2% below the Medical Devices & Instruments industry median of 5.53. 908 Devices' overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For 908 Devices (MASS), the current Receivables Turnover is 1.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $8.68 is trading 24.7% above its estimated GF Value™ of $6.96.
GuruFocus considers 908 Devices to be Modestly Overvalued.
Key valuation signals for MASS:
Receivables Turnover: 1.26
GF Value™: $6.96 vs. price of $8.68 (24.7% above fair value)
Industry Position: 77.2% below the Medical Devices & Instruments median (#312 of 812)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
70GF Score
Get the complete analysis for MASS
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
